Champaign, IL – According to filings with the U.S. Securities and Exchange Commission, Insigna is raising $2,000,000.00 in new funding. Sources indicate as part of senior management President, Jay Ko played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Insigna
How we treat animals matters. Thats why we created EpiFix, a new way to fix animals without painful, risky surgeries and long recoveries. Eliminating invasive surgery is always a good thing, but its the impact that really matters. A low-cost single-injection makes it much easier and cheaper for spay/neuter organizations and shelters to fix homeless animals. That means better health, reduced overpopulation, and a happier life for vulnerable cats and dogs worldwide. The removal of reproductive organs through surgical spays and neuters is incredibly invasive and traumatic to animals, especially for the farm animals on whom these procedures are generally performed without the aid of anesthesia or even sutures to close the surgical site. At Epivara, our Mission is to make life easier and better for animals and humans through innovative science and compassionate care. We can do better, and with Epivaras technologies, we will.

To learn more about Insigna, visit http://insigna.co/

Contact:
Jay Ko, President
833-565-4771
jay.ko@insigna.co
https://www.linkedin.com/in/jay-ko-b823414a/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved